Heyan Li

Induction of PD-L1 Expression by the EML4–ALK Oncoprotein and Downstream Signaling Pathways in Non–Small Cell Lung Cancer

Engineering precision nanoparticles for drug delivery

Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning

Prognostic and predictive biomarkers in lung cancer. A review

Controlled drug delivery vehicles for cancer treatment and their performance

Bioengineering Strategies for Designing Targeted Cancer Therapies

Regulation and Function of the PD-L1 Checkpoint

Ligand-targeted liposome design: challenges and fundamental considerations

Liposomes as nanomedical devices

Precision Cancer Nanotherapy: Evolving Role of Multifunctional Nanoparticles for Cancer Active Targeting

Smart Drug Delivery System

Chemotherapy induces enrichment of CD47 ⁺ /CD73 ⁺ /PDL1 ⁺ immune evasive triple-negative breast cancer cells

Esterase- and pH-responsive poly(β-amino ester)-capped mesoporous silica nanoparticles for drug delivery

A7RC peptide modified paclitaxel liposomes dually target breast cancer

Recent Trends in Multifunctional Liposomal Nanocarriers for Enhanced Tumor Targeting

Important Flavonoids and Their Role as a Therapeutic Agent

Nicotine Induces Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor by α1 Nicotinic Acetylcholine Receptor–Mediated Activation in PC9 Cells

Enhanced antitumor effect of novel dual-targeted paclitaxel liposomes

RGD-targeted paramagnetic liposomes for early detection of tumor: In vitro and in vivo studies